Rosuvastatin calcium tablet and preparation process thereof

A technology for rosuvastatin calcium and a preparation process is applied in the field of rosuvastatin calcium-containing tablets and the preparation process thereof, and can solve the problems of stable rosuvastatin calcium tablets, high fluidity requirements, and poor particle size. Uniformity and other problems, to achieve the effect of easy industrialized large-scale production, solving the release stability, and simple preparation process

Inactive Publication Date: 2015-08-19
KUNMING MEDICAL UNIVERSITY
View PDF7 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This invention does not fundamentally solve the stability problem of rosuvastatin calcium. Since all the excipients have relatively high hygroscopicity, the degradation products will still increase significantly during storage.
At the same time, direct compression has high requirements on the fluidity of excipients, and excipients suitable for direct compression are generally expensive; moreover, rosuvastatin calcium has st

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Rosuvastatin calcium tablet and preparation process thereof
  • Rosuvastatin calcium tablet and preparation process thereof
  • Rosuvastatin calcium tablet and preparation process thereof

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0033] Example 1

[0034]

[0035] Preparation process: Weigh rosuvastatin calcium, polystyrene maleic anhydride copolymer, and poloxamer 407, which have been passed through a 100-mesh sieve in the prescription, add them to absolute ethanol, suspend, and dry under reduced pressure at 40°C to remove the ethanol. The dried product is passed through an 80-mesh sieve, mixed uniformly with the prescribed amount of hydroxypropyl methylcellulose, sodium alginate, and microcrystalline cellulose passed through a 100-mesh sieve, and then mixed with magnesium stearate, and compressed.

Example Embodiment

[0036] Example 2

[0037]

[0038]

[0039] Preparation process: Weigh rosuvastatin calcium, polystyrene maleic anhydride copolymer, and poloxamer 407, which have been passed through a 100-mesh sieve in the prescription, add them to absolute ethanol, suspend, and dry under reduced pressure at 40°C to remove the ethanol. The dried product is passed through an 80-mesh sieve, mixed with the prescribed amount of hydroxypropyl methylcellulose, sodium alginate, and starch passed through a 100-mesh sieve, and then mixed with calcium stearate, and compressed.

Example Embodiment

[0040] Example 3

[0041]

[0042] Preparation process: Weigh rosuvastatin calcium, polystyrene maleic anhydride copolymer, and poloxamer 407, which have been passed through a 100-mesh sieve in the prescription, add them to absolute ethanol, suspend, and dry under reduced pressure at 40°C to remove ethanol The dried product is passed through an 80-mesh sieve, mixed with the prescribed amount of hydroxypropyl methylcellulose, sodium alginate, and mannitol that has passed through a 100-mesh sieve, and then mixed with sodium stearate fumarate and compressed.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a rosuvastatin calcium tablet and a preparation process thereof, and belongs to chemical medicinal preparations. The rosuvastatin calcium tablet is formed by uniformly mixing rosuvastatin calcium solid dispersions with pharmaceutically-acceptable accessories and then carrying out direct compression, the rosuvastatin calcium solid dispersions are obtained by suspending rosuvastatin calcium, a polystyrene maleic anhydride copolymer and poloxamer 407 in absolute ethyl alcohol and drying to remove ethyl alcohol, the rosuvastatin calcium solid dispersions are uniformly mixed with the other pharmaceutically-acceptable accessories, and then the direct compression is carried out. According to the rosuvastatin calcium tablet and the preparation process thereof, the problem of release of the rosuvastatin calcium is successfully solved, and the dissolution stability of the rosuvastatin calcium is remarkably improved.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical preparations, and in particular relates to a pharmaceutical preparation, in particular to a tablet containing rosuvastatin calcium and a preparation process thereof. Background technique [0002] Rosuvastatin Calcium is a white amorphous powder, slightly soluble in water and methanol, very slightly soluble in ethanol. Rosuvastatin calcium is a hydrophilic compound with an oil-water partition coefficient (octanol / water) of 0.13 at pH 7. The chemical name is bis-[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]-pyrimidin-5-yl]( 3R,5S)-3,5-Hydroxyhept-6-enoic acid] calcium salt (2:1), the molecular formula is (C 22 h 27 FN 3 o 6 S) 2 Ca, the structural formula is as follows: [0003] [0004] Pharmacological type: Rosuvastatin calcium is a 3-hydroxy-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, so it can reduce the cholesterol level in plasma. [0005...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K47/34A61K31/505A61K9/20A61K47/38A61K47/36A61P3/06
Inventor 李洋朱海燕
Owner KUNMING MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap